Нарушение баланса аминокислот при печеночной недостаточности и его роль в развитии печеночной энцефалопатии

1. Berry HK, Brunner RL, Hunt MM et al. Valine, isoleucine, and leucine. A new treatment for phenylketonuria. Am J Dis Child 1990; 144: 539–43.
2. Blomstrand E, Hassmen P, Ek S et al. Influence of ingesting a solution of branched-chain amino acids on perceived exertion during exercise. Acta Physiol Scand 1997; 159: 41–9.
3. Blomstrand E, Hassmen P, Ekblom B et al. Administration of branched-chain amino acids during sustained exercise–effects on performance and on plasma concentration of some amino acids. Eur J Appl Physiol 1991; 63: 83–8.
4. Charlton M. Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease. J Nutr 2006; 136: 295S–8S.
5. Chin SE, Sheperd RW, Thomas BJ et al. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992; 56: 158–63.
6. Egberts E-H, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. Gastroenterol 1985; 88: 887–95.
7. Greer BK, Woodard JL, White JP et al. Branched-chain amino acid supplementation and indicators of muscle damage after endurance exercise. Int J Sport Nutr Exerc Metab 2007; 17 (6): 595–607.
8. Hassmеn P, Blomstrand E, Ekblom B, Newshomle EA. Branched-chain amino acid supplementation during 30-km competitive run: mood and cognitive performance. Nutrition 1994; 10: 405–10.
9. Plaitakis A, Smith J, Mandeli J et al. Pilot trial of branched-chain amino acids in amyotrophic lateral sclerosis. Lancet 1988; 1015–20.
10. Maddrey WC. Branched chain amino acid therapy in liver disease. J Am Coll Nutr 1985; 4: 639–50.
11. Naylor CD, O'Rourke K, Detsky AS et al. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 1989; 97: 1033–42.
12. Kato M, Miwa Y, Tajika M et al. Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis. Internal Med 1998; 37: 429–34.
13. Kawaguchi T, Nagao Y, Matsuoka H et al. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med 2008; 22 (1): 105–12.
14. O'Keffe SJD, El-Zayadi A, Carraher T et al. Malnutrition and immune competence in patients with liver disease. Lancet 1980; ii: 615–7.
15. O'Keffe SJD, Abraham R, El-Zayadi A et al. Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepaic oxidation capacity. Gastroenterology 1981; 81: 1014–24.
16. Silk D B Branched chain amino acids in liver disease: fact or fantasy? Gut 1986; 27 (Suppl. 1): 103–10.
17. Soreide E, Skeie B, Kirvela O et al. Branched-chain amino acid in chronic renal failure atients: respiratory and sleep effects. Kidney Int 1991; 40: 539–43.
18. Wahren J, Denis J, Desurmont P et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 1983; 3 (4): 475–80.
19. Young VR, Bier DM, Pellett PL. A theoretical basis for increasing current estimates of the amino acid requirements in adult man, with experimental support. Am J Clin Nutr 1989; 50: 80–92.
20. Zello GA, Wykes LF, Ball RO et al. Recent advances in methods of assessing dietary amino acid requirements for adult humans. J Nutr 1995; 125: 2907–15.